Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.960
-0.300 (-5.70%)
At close: May 15, 2026, 4:00 PM EDT
4.975
+0.015 (0.30%)
After-hours: May 15, 2026, 6:02 PM EDT
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $116.35 million as of May 15, 2026. Its market cap has increased by 10.77% in one year.
Market Cap
116.35M
Enterprise Value
65.62M
1-Year Change
10.77%
Ranking
Category
Stock Price
$4.96
Market Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $116.35M, an increase of 882.90%. That is a compound annual growth rate of 96.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 116.35M | -4.13% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 126.41M |
| Turn Therapeutics | 120.64M |
| Edesa Biotech | 115.96M |
| enGene Therapeutics | 115.22M |
| Cardiff Oncology | 114.18M |
| Kalaris Therapeutics | 113.47M |
| NRx Pharmaceuticals | 108.35M |
| Rani Therapeutics Holdings | 107.80M |